Sign up
Quantellect · Analysts · Analyst Profile
Q Score Rank#232 of 388

Pete Stavropoulos

Cantor Fitzgerald · Equity Research Analyst
ProvisionalRating since 2023No new ratings since Jul 2025

Analyst rating accuracy & track record

Pete Stavropoulos is an equity research analyst at Cantor Fitzgerald. Quantellect has scored 23 of their stock calls across 10 companies. Their picks beat their sector 34% of the time over the next 12 months, and their price targets were reached of the time within a year.

Win % vs sector
34%
PT Hit % (12mo)
Avg sector-excess
−8.6%
Scored calls
23
Tickers
10
Tier
Provisional

Track record

Quantellect has scored 23 of Pete Stavropoulos's stock calls across 10 companies, dating back to 2023. Their rated stocks beat their own sector 34% of the time over the next 12 months. On a typical call, a Stavropoulos pick returned −8.6% more than its sector over the following year.

Of the scored calls, 23 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
ELDNEledon Pharmaceuticals Inc
BuyJul 2025−7.9%
ELDNEledon Pharmaceuticals Inc
BuyJul 2025−7.9%
DRUGBright Minds Biosciences Inc
BuyJul 2025+115.9%
DRUGBright Minds Biosciences Inc
BuyJul 2025+115.9%
ARCTArcturus Therapeutics Holdings Inc
BuyJul 2025−68.8%
VYGRVoyager Therapeutics Inc
BuyMar 2025+13.4%
ARCTArcturus Therapeutics Holdings Inc
BuyMar 2025−54.8%
VYGRVoyager Therapeutics Inc
Buy$5.73Jan 2025−39.3%Hit
KALVKalvista Pharmaceuticals Inc
BuyDec 2024+65.3%
ALECAlector Inc
BuyNov 2024−56.7%
ANNXAnnexon Inc
BuyNov 2024−53.5%
VSTMVerastem Inc
BuyOct 2024+127.3%
ALECAlector Inc
BuyJul 2024−65.3%
ALECAlector Inc
BuyJun 2024−59.6%
ANNXAnnexon Inc
BuyJun 2024−49.2%
ALECAlector Inc
BuyMay 2024−71.6%
ANNXAnnexon Inc
BuyApr 2024−58.2%
ANNXAnnexon Inc
BuyApr 2024−73.8%
JSPRJasper Therapeutics Inc
Buy$6.00Oct 2023+52.1%Miss
ALECAlector Inc
Buy$13.00Sep 2023−41.8%Miss
ABOSAcumen Pharmaceuticals Inc
Buy$13.00May 2023−52.0%Miss
JSPRJasper Therapeutics Inc
Buy$6.00Mar 2023+39.3%Miss
JSPRJasper Therapeutics Inc
Buy$6.00Feb 2023−16.3%Miss
Go to

Pete Stavropoulos: analyst track record FAQ

Is Pete Stavropoulos a good stock analyst?

Yes, by track record. Pete Stavropoulos ranks number 232 of 388 of the analysts Quantellect scores, with a Q Score of 24 out of 100. Past results do not guarantee future ones.

What is Pete Stavropoulos's win rate?

Pete Stavropoulos's win rate is 34%. Across 23 scored calls, their rated stocks beat their sector 34% of the time over the next 12 months. On a typical call they returned −8.6% more than the sector.

What stocks and sectors does Pete Stavropoulos cover?

Pete Stavropoulos covers 10 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Pete Stavropoulos's price targets accurate?

Pete Stavropoulos's price targets are reached within 12 months — of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Pete Stavropoulos's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Pete Stavropoulos rank among Wall Street analysts?

Pete Stavropoulos ranks number 232 of 388 by Q Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.